![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
Previous Article | Next Article 
Journal of Clinical Microbiology, September 2006, p. 3279-3284, Vol. 44, No. 9
0095-1137/06/$08.00+0 doi:10.1128/JCM.00014-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Laboratoire de Parasitologie-Mycologie, CHU Brabois, 54500 Vandoeuvre-les-Nancy, France,1 Hôpital d'Instruction des Armées Legouest, 57998 Metz, France,2 Service Regional Universitaire des Maladies Infectieuses et du Voyageur, Hôpital DRON, 59200 Tourcoing, France3
Received 4 January 2006/ Returned for modification 17 February 2006/ Accepted 15 June 2006
 |
ABSTRACT |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
|
INTRODUCTION |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
In this study, we have developed and evaluated a PCR followed by CovaLink NH microwell plate hybridization (CMPH) for qualitative detection and identification of four malaria species from human blood samples. First, the 18S rRNA gene was chosen as an amplification target in a PCR using Plasmodium genus-specific primers, one of which was biotinylated. A nonradioactive hybridization assay was then used for the detection of the biotinylated PCR product. The method employed four species-specific capture probes covalently immobilized onto polystyrene microwells by a phosphoramidate bond. The hybrid molecules were detected by a streptavidin-peroxidase complex and its chromogenic substrate (Fig. 1). We present a clinical retrospective study of this PCR-CMPH method using blood samples from 56 patients returning from areas where malaria is endemic. The results are compared with results from conventional diagnosis techniques and other molecular biology tools.
|
|
MATERIALS AND METHODS |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Treatment of blood samples. Briefly, 500 µl of thawed whole blood was pretreated with 10 µl of a 10% saponin solution and vortexed. The pellets were recovered after 5 min of centrifugation at 8,000 x g and resuspended in 25 µl of lysis buffer (40 mM Tris-HCl, pH 8.0, 80 mM EDTA, pH 8.0, 2% sodium dodecyl sulfate [SDS]) (19, 20). DNA was then extracted by using either a QIAamp DNA Mini kit (QIAGEN, France) or the MagNA Pure LC automated system (Roche Diagnostics, France) with the MagNA Pure LC Microbiology Kit MGrade according to the manufacturer's instructions. Samples were kept at –80°C until use.
Target sequences, primers, and probes. First, one consensus primer set was selected to amplify the 18S rRNA gene of four Plasmodium species from human blood samples. The 5'-end-biotinylated sense primer (Biot-rPLU6 [5'-TTAAAATTGTTGCAGTTAAAACG-3']; Proligo, France) corresponds to a common sequence of P. falciparum, P. ovale, P. malariae, and P. vivax previously described by Snounou et al. (19, 20). The antisense primer (PR3 [5'-GTTATTCCATGCTGTAGTATTC-3']) was designed in another conserved domain obtained after an alignment of published sequences available in the GenBank database (Fig. 2). In contrast to the primer pair, sequences corresponding to the P. falciparum, P. ovale, and P. vivax probes were selected in variable domains according to a method described previously by Whiley et al. (22). The previous 18S rRNA sequence alignment allowed us to design a P. malariae-specific probe (Fig. 2).
|
The reaction mixture volume was adjusted to 50 µl with ultrapure water. PCR amplification was performed using an iCycler IQ system (Bio-Rad, France) under the following conditions: initial denaturation of DNA at 94°C for 3 min, followed by 30 cycles at 94°C for 1 min, 58°C for 40 s, and 72°C for 1 min. Those steps were followed by an additional 5-min extension step at 72°C. Five microliters of PCR product was electrophoresed in a 2% agarose gel in the presence of ethidium bromide and visualized under UV light. The expected Plasmodium genus PCR product size was 300 bp.
In order to address the discrepant results obtained between microscopy and PCR-CMPH hybridization, STEVOR and nested PCR were performed under the conditions described previously by Filisetti et al. and Snounou et al., respectively (5, 19, 20).
CovaLink NH microwell plate hybridization and colorimetric detection. (i) Procedure for probe covalent binding to CovaLink NH strips. Species-specific capture probes detecting P. falciparum, P. vivax, P. ovale, or P. malariae were phosphorylated at the 5' end and high-performance liquid chromatography purified (Proligo, France). Each probe was covalently bound to the polystyrene surface of CovaLink NH microwell strips (VWR International, France) as described previously by Rasmussen et al. (17). Briefly, each phosphorylated probe (concentrations between 25 and 75 pmol/well) was denatured for 10 min at 95°C and rapidly cooled on ice to prevent secondary structure formation. Cold 0.1 M 1-methylimidazole (1-Mi) (pH 7.0; Sigma, France) was added to a final concentration of 10 mM 1-Mi. The mixture was dispensed (75 µl/well) into CovaLink NH microwell strips standing on ice. Twenty-five microliters of freshly prepared 2 M 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC; Sigma, France) dissolved in 10 mM 1-Mi was then added to each well. Several final concentrations of EDC varying from 5 µM to 500 mM were tested. The sealed microwell plate was then incubated for 5 h at 50°C. After incubation, the solution was removed, and each well was washed three times with a washing solution (0.4 N NaOH containing 0.25% SDS) heated to 50°C. The microwells were then soaked for 5 min and washed again three times using the same heated washing solution. Finally, the plate was washed an additional six times at room temperature with Tris-EDTA (10 mM Tris-HCl, pH 8.0, 1 mM EDTA). The coated strips filled with Tris-EDTA can be stored at 4°C for several months. Before being used, the coated strips were washed twice with TTSS buffer (10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.1% Tween 20, 0.1% SDS).
(ii) Hybridization assay. A variable volume of ultrapure water was added into a tube containing 40 to 80 µl of Plasmodium genus PCR product, yielding a final volume of 100 µl. After denaturation for 10 min at 95°C followed by rapid cooling on ice, 670 µl of water and 770 µl of SSBP buffer (30 mM sodium citrate-1.91 M NaCl, pH 7.0, containing 2% sarkosyl and 1% polyvinylpyrrolidone-360K) were added. The contents of the tube were transferred into wells coated with specific probes for P. falciparum, P. vivax, P. ovale, or P. malariae (175 µl/well).
All samples were analyzed in duplicate. The sealed strips were left to incubate at 42°C for 1 h. The solution was then removed, and the wells were washed six times with 300 µl of TTSS buffer at 58°C. Finally, 180 µl of peroxidase-labeled streptavidin (Roche Diagnostics, France) diluted 1:500 with TTSS buffer was added to each well, and incubation was performed for 1 h in darkness at room temperature. After six washings with 300 µl of TTSS buffer, 200 µl of chromogenic substrate (3,3',5,5'-tetramethylbenzidine; Sigma) heated at 37°C was added, and the wells were incubated for 5 min in darkness. Coloration development was stopped with 30 µl of 1.6 M H2SO4, and the optical density for each well was determined by using a Behring Processor III spectrophotometer (Dade Behring, France) at a wavelength of 450 nm with 690 nm as a reference. The background noise corresponds to the mean absorbance measured in a coated well that did not receive the PCR product. An absorbance three times higher than the background noise (background noise + 3 standard deviations) is indicative of a positive result (9, 16). The signal obtained for 5'-end-biotinylated oligonucleotides with sequences complementary to the probes (400 fmol/well) was considered optimal and was therefore used as a positive control in every hybridization assay.
Sequencing of PCR products. Four original sets of Plasmodium species-specific primers were designed to sequence some PCR products showing discrepancies between microscopy and PCR-CMPH (Table 1). The amplicons were first purified by using a QIAquick PCR purification kit (QIAGEN, France). Five microliters of purified PCR products was electrophoresed in a 2% agarose gel in the presence of ethidium bromide and visualized under UV light in order to evaluate its concentrations using the quantified Smartladder as a reference (Eurogentec, Belgium). The two strands of amplified DNA were then sequenced by using the PCR primers (Table 1) and the BigDye Terminator v1.1. cycle sequencing kit according to the manufacturer's instructions (Applied Biosystems, France). Briefly, in a final volume of 10 µl, 1 µl of PCR product was added to 2 µl of mix, 1 µl of buffer, and 1.6 pmol of primer. Sequencing reactions were performed using a thermal iCycler IQ system (Bio-Rad, France) with a first step of denaturation at 96°C for 1 min, followed by 25 amplification cycles at 96°C for 10 s, 50°C for 5 s, and 60°C for 4 min. The resulting products were then purified by a succession of washing and centrifugation steps. Finally, the pellets were resuspended and analyzed using an automated sequencer (ABI Prism 3100 Genetic analyzer). Similarity searches were performed by using the Blastn program at the NCBI website (http://www.ncbi.nlm.nih.gov/BLAST/).
|
|
RESULTS |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Optimization of CMPH. Optimization was performed by varying the EDC concentrations with serial 10-fold dilutions from 5 µM to 500 mM. For concentrations below 5 mM, the signal-to-noise (S/N) ratio fell proportionally to the EDC concentration decrease (data not shown). Therefore, the 50 mM concentration was considered optimal.
When the amount of probe went up from 25 pmol to 75 pmol, with 5 or 10 µl of the PCR product, the S/N ratio increase was not proportional, but in all cases, the signal remained in the acceptable range for positive detection. It was not thought to be worthwhile to increase the amount of probe beyond 50 pmol, as this would have made the development of a routine assay and epidemiological study too expensive (Table 2).
|
Detection and species-specific identification of PCR products by CMPH. The results for the 79 blood samples tested with PCR-CMPH were compared to results obtained by conventional microscopy and molecular biology methods.
In order to evaluate the sensitivity of the assay, a human blood sample infected with P. falciparum (1.25 x 104 parasites/µl) was serially 10-fold diluted with uninfected human blood and tested by PCR-CMPH. The limit of PCR-CMPH detection from whole blood is approximately 10 parasites/µl, corresponding to a parasitemia level of 0.00025% and taking 5 x 106 erythrocytes/µl as a reference.
A comparison of results obtained by blood smear microscopy and PCR-CMPH showed complete concordance in the diagnosis of malaria for 47 of the 56 patients tested (84%) (Table 3).
|
Five patients for whom the malaria diagnosis was excluded on the basis of microscopy and immunochromatographic test (ICT Now Malaria) were found to be noninfected when PCR-CMPH was used with the four probes.
Results disagreed for nine patients (Table 3). Two patients had negative microscopy results, but one of them, positive by the ICT Now Malaria test, was identified as being positive for P. ovale by PCR-CMPH (S/N ratio of 25.25). P. falciparum was detected in the second negative sample identified by microscopy (S/N ratio of 13.48). Those PCR-CMPH results were confirmed by nested PCR and DNA sequencing, proving the presence of P. ovale in the first case and P. falciparum in the second case. For five patients, PCR-CMPH detected P. ovale or P. vivax, whereas light microscopy identified P. vivax or P. ovale, or vice versa. For these results, the evidence was supported by nested PCR and further examination of the blood films. For three patients, light microscopy identified the parasite as P. ovale or P. vivax only, whereas PCR-CMPH detected mixed infections (one of the former plus P. falciparum); the presence of P. falciparum was confirmed by sequencing. Finally, in one case, PCR-CMPH was negative although P. falciparum was found by microscopy, STEVOR PCR, and nested PCR.
Moreover, negative controls were tested with blood from patients that were addressed in the hospital for other pathologies (toxoplasmosis, invasive mycosis, etc.). No cross-reaction was observed for these samples with the four probes.
|
DISCUSSION |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
In this study, we developed a PCR followed by nonradioactive hybridization using oligonucleotides covalently bound by their 5' end to CovaLink NH microwells for the detection and identification of four Plasmodium species detected in human blood samples. The microwell surface was evaluated in order to develop a simple, sensitive, and specific strategy with a genus-specific PCR to detect the presence of the Plasmodium spp. Next, in a rapid hybridization step, amplicons were identified by species-specific capture probes.
Previous studies have described the hybridization ability of an oligonucleotide covalently attached to CovaLink NH microwells (2, 17). The microwell surface has secondary amine groups positioned at the end of a spacer arm covalently grafted onto the polystyrene. The oligonucleotide is covalently linked by its 5'-terminal phosphate group to the surface by means of a phosphoramidate bond (16). This method was applied recently to detect pathogenic bacteria by sandwich hybridization using a capture probe and a biotin-labeled oligonucleotide (10).
To perform this hybridization step, EDC is necessary to activate the phosphate group located at the 5' end of the probe. Rasmussen et al. (17) have previously shown that with an EDC concentration of 50 mM, 85% of the 5'-end-phosphorylated DNA molecules were bound exclusively by the 5' end, which is particularly suitable for hybridization. On the other hand, Lund et al. previously reported that carbodiimide may modify the bases of nucleic acids, causing a nonspecific attachment of DNA, and this can be deleterious to hybridization (12). Therefore, the EDC concentration was evaluated in order to obtain the optimal S/N ratio by reducing either the noncovalent binding or the nonexclusive attachment by the 5' end or by avoiding potential chemical changes in the bases of nucleotides. A 10-fold increase or decrease of the initial 50 mM concentration, as suggested previously by Rasmussen, did not show any significant change in the S/N ratio. The 50 mM concentration was therefore left unchanged.
In this assay, 79 blood samples were selected from 56 patients with suspected malaria infection who had traveled in areas where malaria is endemic. All samples were tested by PCR-CMPH and classical diagnosis techniques, and results were compared. For 47 out of 56 patients (84%), microscopy and PCR-CMPH were in agreement. For the remaining nine patients, PCR-CMPH corrected and completed the identification made by microscopy. Thus, three mixed infections were identified by PCR-CMPH, whereas classical diagnosis methods (microscopy and antigen detection) did not recognize them. It is generally considered that one species of parasite may influence the prevalence of another in mixed infections (13). This could explain why it is difficult to detect mixed infections by routine microscopy, particularly when only one blood sample is available. PCR-CMPH clearly offers an advantage in this situation.
In five cases, the microscopy results were proven to be wrong because of confusion between P. vivax and P. ovale. Such a mistake, resulting from morphological similarities, happens frequently even with experienced observers, especially when those observers lack information about the clinical and travel history of the patient.
Microscopy was negative for two blood samples, although PCR-CMPH detected a potentially fatal P. falciparum infection in one case and P. ovale with possible relapse in the other case. PCR-CMPH, with a sensitivity of about 10 parasites/µl, can detect parasitemia below the detection level of microscopy (the absolute detection limit of microscopy is about 50 parasites/µl) (7, 22).
In contrast, we encountered one case of P. falciparum infection detected by microscopy and confirmed by two PCR techniques (STEVOR PCR and nested PCR), but PCR-CMPH labeled it as negative; the DNA was amplified but undetected by hybridization. The discrepancy was probably due to a sequence mismatch that was able to decrease probe affinity significantly. This suggestion was made previously by Kimura et al. (9) and Whiley et al. (22), who used similar hybridization techniques for P. vivax strains in which such mismatches occurred. In our study, we have aligned the sequences available in the GenBank database in order to assess the specificity of the probes chosen by Whiley et al. and to design a specific P. malaria probe. The bioinformatics study was extended with TIGR (http://www.tigr.org/index.shtml) and Plasmo-DB (http://plasmodb.org) databases, which comprise a higher sequence number, exclusively concerning P. falciparum and P. vivax. The BlastN search made between the P. falciparum and P. vivax probe sequences and the corresponding 18S sequences have revealed variable homologies. This can significantly decrease probe affinity. Nevertheless, in spite of this theoretic variability, in our study, each probe was able to detect all the blood samples except one.
In conclusion, our results show that PCR-CMPH has advantages over microscopy in detecting mixed infections and correcting species identification errors. This can be of great value for successful medical treatment and also for epidemiological studies. Whereas a diagnosis of malaria is a matter of urgency, PCR-CMPH is not a "rapid test" and should be used to confirm and complete the microscopic examination.
Compared to hybridization techniques described previously by other authors such as Whiley et al., who used expensive streptavidin-coated microwells, it is easier, as in the PCR-CMPH test, to directly bind the probe onto the polystyrene surface (22). Concerning the labeling, only one of both consensus primers is biotinylated in the amplification, whereas in the latter technique, a second marker is necessary to detect the PCR product (digoxigenin-anti-digoxigenin peroxidase conjugate).
In the last few years, other new methodologies such as real-time PCR have been developed (1, 2, 4, 18). Real-time PCR employs fluorescent labels to monitor amplicon formation throughout the reaction. This technology was adapted to the qualitative and quantitative detection of all four malaria parasites that infect humans and is suitable for the screening of large numbers of samples (11). It offers a rapid and accurate alternative for the diagnosis of malaria. However, the high cost of this technique prevents it from being introduced into developing countries. Moreover, it needs to be handled by highly qualified personnel.
On the contrary, PCR-CMPH is technically simple and easy to handle. It uses stable reagents: precoated strips stored at 4°C can be employed for up to 10 months (2). It does not require electrophoresis with toxic reagents such as ethidium bromide and can be operated with simple enzyme-linked immunosorbent assay material. It is rapid and allows the simultaneous detection and differentiation of all Plasmodium species that infect humans within 6 h after receipt of clinical samples. Finally, PCR-CMPH could be automated, thus permitting the comparative analysis of many samples in parallel, and is adaptable for routine epidemiological use in areas where malaria is endemic.
|
FOOTNOTES |
|---|
|
REFERENCES |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|
